UNITE: Efficacy and impact of fremanezumab in patients with migraine and major depressive disorder

被引：0
|
作者：
Ramirez Campos, V. [1 ]
Lipton, R. B. [2 ]
Krasenbaum, L. J. [1 ]
Ning, X. [1 ]
Barbanti, P. [3 ,4 ]
Roth-Ben Arie, Z. [5 ]
Galic, M. [6 ]
Denysenko, L. [7 ,8 ]
Marmura, M. [7 ]
McAllister, P. [9 ]
Mitsikostas, D. D. [10 ]
机构：
[1] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[2] Albert Einstein Coll Med, Dept Neurol Psychiat & Behav Sci, New York, NY USA
[3] IRCCS San Raffaele Roma, Headache & Pain Unit, Rome, Italy
[4] San Raffaele Univ, Rome, Italy
[5] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel
[6] TEVA PHARMA, Prod Farmaceut Lda, Porto Salvo, Portugal
[7] Thomas Jefferson Univ Hosp, Dept Neurol, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[8] Thomas Jefferson Univ Hosp, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA
[9] New England Inst Neurol & Headache, Stamford, CT USA
[10] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, Athens, Greece
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P028
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
    Cao, Bing
    Park, Caroline
    Subramaniapillai, Mehala
    Lee, Yena
    Lacobucci, Michelle
    Mansur, Rodrigo B.
    Zuckerman, Hannah
    Phan, Lee
    McIntyre, Roger S.
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [22] Efficacy of fremanezumab in patients with chronic and episodic migraine stratified by migraine frequency
    Nahas, Stephanie
    Ning, Xiaoping
    Campos, Verena Ramirez
    Barash, Steve
    Cohen, Joshua
    Silberstein, Stephen
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 216 - 217
  • [23] Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder
    Hung, Ching-I
    Liu, Chia-Yih
    Yang, Ching-Hui
    Wang, Shuu-Jiun
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 66 (01) : 8 - 16
  • [24] The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
    Silberstein, S. D.
    Ashina, S.
    Katsarava, Z.
    Bibeau, K.
    Seminerio, M. J.
    Harlow, D.
    Cohen, J. M.
    HEADACHE, 2018, 58 : 76 - 77
  • [25] The impact of fremanezumab on medication overuse in patients with chronic migraine
    Silberstein, Stephen D.
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael J.
    Harlow, Danielle E.
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [26] The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Bibeau, Kristen
    Seminerio, Michael J.
    ANNALS OF NEUROLOGY, 2018, 84 : S84 - S85
  • [27] The Impact of Fremanezumab on Medication Overuse in patients With Chronic Migraine
    Silberstein, Stephen
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael
    Harlow, Danielle
    Cohen, Joshua
    NEUROLOGY, 2019, 92 (15)
  • [28] EFFICACY OF DULOXETINE ON FUNCTIONAL IMPAIRMENT IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Sheehan, David V.
    Meyers, Adam L.
    Ahl, Jonna
    Prakash, Apurva
    Oakes, Tina Marie Myers
    Kelin, Katarina
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 : A63 - A63
  • [29] EFFICACY TRIAL OF A-75200 IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    CUTLER, NR
    SRAMEK, JJ
    KASKIN, K
    GREBB, J
    KENNEDY, S
    SADD, C
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 679 - 679
  • [30] The efficacy of citalopram or escitalopram in patients with asthma and major depressive disorder
    Agarwal, Catherine D.
    Palka, Jayme M.
    Gajewski, Alexander J.
    Khan, David A.
    Brown, Sherwood
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03) : 374 - 382
12345